- Filed
- Nov 14, 2022 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2022 · Nov 10, 2022 | 139.54M sh |
| Shares Diluted | Q3 2022 · Sep 30, 2022 | 138.96M sh |
| Shares Diluted | Q3 2022 · Sep 30, 2022 | 138.37M sh |
| Shares Diluted | Q3 2022 · Sep 30, 2021 | 112.24M sh |
| Shares Diluted | Q3 2022 · Sep 30, 2021 | 110.96M sh |
| Capex | Q3 2022 · Sep 30, 2022 | $2.4M |
| Capex | Q3 2022 · Sep 30, 2021 | $2.38M |
| Operating Cash Flow | Q3 2022 · Sep 30, 2022 | −$89.62M |
| Operating Cash Flow restated | Q3 2022 · Sep 30, 2021 | −$69.2M |
| Long Term Debt | Q3 2022 · Sep 30, 2022 | $0 |
| Short Term Debt | Q3 2022 · Sep 30, 2022 | $27.46M |
| Short Term Debt | Q3 2022 · Dec 31, 2021 | $26.99M |
| Short Term Investments | Q3 2022 · Sep 30, 2022 | $23.93M |
| Short Term Investments | Q3 2022 · Dec 31, 2021 | $5M |
| Cash And Equivalents | Q3 2022 · Sep 30, 2022 | $59.69M |
| Cash And Equivalents | Q3 2022 · Dec 31, 2021 | $169.57M |
| Stockholders Equity | Q3 2022 · Sep 30, 2022 | $52.25M |
| Stockholders Equity | Q3 2022 · Jun 30, 2022 | $79.04M |
| Stockholders Equity | Q3 2022 · Mar 31, 2022 | $69.51M |
| Stockholders Equity | Q3 2022 · Dec 31, 2021 | $90.43M |
| Stockholders Equity restated | Q3 2022 · Sep 30, 2021 | $27.96M |
| Stockholders Equity restated | Q3 2022 · Jun 30, 2021 | $58.2M |
| Stockholders Equity restated | Q3 2022 · Mar 31, 2021 | $85.56M |
| Stockholders Equity restated | Q3 2022 · Dec 31, 2020 | $87.12M |
| Current Liabilities | Q3 2022 · Sep 30, 2022 | $48.16M |
| Current Liabilities | Q3 2022 · Dec 31, 2021 | $47.17M |
| Total Liabilities | Q3 2022 · Sep 30, 2022 | $67.49M |
| Total Liabilities | Q3 2022 · Dec 31, 2021 | $106.73M |
| Current Assets | Q3 2022 · Sep 30, 2022 | $98.87M |
| Current Assets | Q3 2022 · Dec 31, 2021 | $185.24M |
| Total Assets | Q3 2022 · Sep 30, 2022 | $119.74M |
| Total Assets | Q3 2022 · Dec 31, 2021 | $197.16M |
| Eps Diluted | Q3 2022 · Sep 30, 2022 | −$0.22 |
| Eps Diluted | Q3 2022 · Sep 30, 2022 | −$0.35 |
| Eps Diluted | Q3 2022 · Sep 30, 2021 | −$0.28 |
| Eps Diluted | Q3 2022 · Sep 30, 2021 | −$0.76 |
| Eps Basic | Q3 2022 · Sep 30, 2022 | −$0.22 |
| Eps Basic | Q3 2022 · Sep 30, 2022 | −$0.35 |
| Eps Basic | Q3 2022 · Sep 30, 2021 | −$0.28 |
| Eps Basic | Q3 2022 · Sep 30, 2021 | −$0.76 |
| Sga Expense | Q3 2022 · Sep 30, 2022 | $17.77M |
| Sga Expense | Q3 2022 · Sep 30, 2022 | $61.51M |
| Sga Expense | Q3 2022 · Sep 30, 2021 | $17.97M |
| Sga Expense | Q3 2022 · Sep 30, 2021 | $45.81M |
| Rd Expense | Q3 2022 · Sep 30, 2022 | $10.39M |
| Rd Expense | Q3 2022 · Sep 30, 2022 | $36.37M |
| Rd Expense | Q3 2022 · Sep 30, 2021 | $9.58M |
| Rd Expense | Q3 2022 · Sep 30, 2021 | $24.94M |
| Net Income | Q3 2022 · Sep 30, 2022 | −$30.72M |
| Net Income | Q3 2022 · Sep 30, 2022 | −$49.12M |
| Net Income | Q3 2022 · Jun 30, 2022 | $5.46M |
| Net Income | Q3 2022 · Mar 31, 2022 | −$23.86M |
| Net Income restated | Q3 2022 · Sep 30, 2021 | −$31.3M |
| Net Income restated | Q3 2022 · Sep 30, 2021 | −$83.89M |
| Net Income restated | Q3 2022 · Jun 30, 2021 | −$28.2M |
| Net Income restated | Q3 2022 · Mar 31, 2021 | −$24.39M |
| Operating Income | Q3 2022 · Sep 30, 2022 | −$26.63M |
| Operating Income | Q3 2022 · Sep 30, 2022 | −$94.19M |
| Operating Income restated | Q3 2022 · Sep 30, 2021 | −$28.35M |
| Operating Income restated | Q3 2022 · Sep 30, 2021 | −$71.45M |
| Cost Of Revenue | Q3 2022 · Sep 30, 2022 | $2.56M |
| Cost Of Revenue | Q3 2022 · Sep 30, 2022 | $6.44M |
| Cost Of Revenue | Q3 2022 · Sep 30, 2021 | $2.12M |
| Cost Of Revenue | Q3 2022 · Sep 30, 2021 | $3.59M |
| Revenue | Q3 2022 · Sep 30, 2022 | $4.08M |
| Revenue | Q3 2022 · Sep 30, 2022 | $10.13M |
| Revenue | Q3 2022 · Sep 30, 2021 | $1.31M |
| Revenue | Q3 2022 · Sep 30, 2021 | $2.89M |